Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe SPRINT clinical trial record is now displayed instead of an error page, with details about the completed study, its treatment approach, eligibility criteria, outcome measures, collaborators, and study documents.SummaryDifference50%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study record remains inaccessible.SummaryDifference0.2%

- Check18 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial record page continues to display a 403 error.SummaryDifference1%

- Check25 days agoChange DetectedThe footer’s site revision number changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedAccess to the study record page now results in a 403 Forbidden error. The page displays a standard error message and site chrome, indicating an access restriction rather than a content update.SummaryDifference18%

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.